Ueno H - Search Results

1

A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer.

Ikeda M, Okusaka T, Ito Y, Ueno H, Morizane C, Furuse J, Ishii H, Kawashima M, Kagami Y, Ikeda H. Ikeda M, et al. Among authors: ueno h. Br J Cancer. 2007 Jun 4;96(11):1650-5. doi: 10.1038/sj.bjc.6603788. Epub 2007 May 29. Br J Cancer. 2007. PMID: 17533388 Free PMC article. Clinical Trial.

2

Phase I trial of gemcitabine in patients with advanced pancreatic cancer.

Okada S, Ueno H, Okusaka T, Ikeda M, Furuse J, Maru Y. Okada S, et al. Among authors: ueno h. Jpn J Clin Oncol. 2001 Jan;31(1):7-12. doi: 10.1093/jjco/hye003. Jpn J Clin Oncol. 2001. PMID: 11256843 Clinical Trial.

3

A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.

Ikeda M, Okada S, Tokuuye K, Ueno H, Okusaka T. Ikeda M, et al. Among authors: ueno h. Br J Cancer. 2002 May 20;86(10):1551-4. doi: 10.1038/sj.bjc.6600256. Br J Cancer. 2002. PMID: 12085203 Free PMC article. Clinical Trial.

4

Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer.

Okusaka T, Ito Y, Ueno H, Ikeda M, Takezako Y, Morizane C, Kagami Y, Ikeda H. Okusaka T, et al. Among authors: ueno h. Br J Cancer. 2004 Aug 16;91(4):673-7. doi: 10.1038/sj.bjc.6602001. Br J Cancer. 2004. PMID: 15226765 Free PMC article. Clinical Trial.

5

Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin.

Matsumura Y, Hamaguchi T, Ura T, Muro K, Yamada Y, Shimada Y, Shirao K, Okusaka T, Ueno H, Ikeda M, Watanabe N. Matsumura Y, et al. Among authors: ueno h. Br J Cancer. 2004 Nov 15;91(10):1775-81. doi: 10.1038/sj.bjc.6602204. Br J Cancer. 2004. PMID: 15477860 Free PMC article. Clinical Trial.

6

Phase II study of S-1 in patients with advanced biliary tract cancer.

Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C. Ueno H, et al. Br J Cancer. 2004 Nov 15;91(10):1769-74. doi: 10.1038/sj.bjc.6602208. Br J Cancer. 2004. PMID: 15505626 Free PMC article. Clinical Trial.

7

A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation.

Hamaguchi T, Kato K, Yasui H, Morizane C, Ikeda M, Ueno H, Muro K, Yamada Y, Okusaka T, Shirao K, Shimada Y, Nakahama H, Matsumura Y. Hamaguchi T, et al. Among authors: ueno h. Br J Cancer. 2007 Jul 16;97(2):170-6. doi: 10.1038/sj.bjc.6603855. Epub 2007 Jun 26. Br J Cancer. 2007. PMID: 17595665 Free PMC article.

8

Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients.

Ueno H, Kaniwa N, Okusaka T, Ikeda M, Morizane C, Kondo S, Sugiyama E, Kim SR, Hasegawa R, Saito Y, Yoshida T, Saijo N, Sawada J. Ueno H, et al. Br J Cancer. 2009 Mar 24;100(6):870-3. doi: 10.1038/sj.bjc.6604971. Br J Cancer. 2009. PMID: 19293806 Free PMC article.

9

Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma.

Kondo S, Ueno H, Hosoi H, Hashimoto J, Morizane C, Koizumi F, Tamura K, Okusaka T. Kondo S, et al. Among authors: ueno h. Br J Cancer. 2013 Aug 6;109(3):739-46. doi: 10.1038/bjc.2013.348. Epub 2013 Jul 4. Br J Cancer. 2013. PMID: 23828517 Free PMC article.

10

ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer.

Watanabe T, Ueno H, Watabe Y, Hiraoka N, Morizane C, Itami J, Okusaka T, Miura N, Kakizaki T, Kakuya T, Kamita M, Tsuchida A, Nagakawa Y, Wilber H, Yamada T, Honda K. Watanabe T, et al. Among authors: ueno h. Br J Cancer. 2015 Feb 17;112(4):704-13. doi: 10.1038/bjc.2014.623. Epub 2015 Jan 20. Br J Cancer. 2015. PMID: 25602965 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,580 results

Search Page

Filters